Follow-The-Filings

Security · featured owners

ADPT Adaptive Biotechnologies Cor

Health Care COM Equity as of 2026 Q2 among managers we track

  • 3 Owners
  • Max 1.8%
  • $690M
  • 2 reduce 1 exit

ADPT (Adaptive Biotechnologies Cor) is held in 3 featured 13F books as of 2026 Q2. Andreas Halvorsen - Viking Global Investors is the largest tracked holder by portfolio weight (1.8%). Figures are as-filed 13F, not free float.

Who owns this now

Largest portfolio weights among featured holders · max 1.8% (Andreas Halvorsen - Viking Global Investors) · not free-float ownership

  1. Andreas Halvorsen 1.8%
  2. Cathie Wood reduce 0.29%
  3. Polen Capital Management reduce 0.02%

holders

sorted by value · long equity only · current book 2026 Q2 · open a manager for their book

history
Andreas Halvorsen - Viking Global Investors 2026 Q2 1.8% Hold 29,993,708 $643M history
Cathie Wood - Ark Investment Management 2026 Q2 0.29% Reduce −0.1% 2,090,306 $45M history
Polen Capital Management 2026 Q2 0.02% Reduce −11.7% 102,457 $2M history
Farallon Capital Management exited 2026 Q2 last 2026 Q1 <0.01% Exit 0.00% 11,000 $153K history

3 current · 1 exited last period · options excluded

SEC filings

Recent issuer filings from EDGAR · 8 shown · open Filing / Doc on SEC.gov

Filed Form Detail Links
10-Q Filing Doc
8-K 2.02,5.02,9.01 Filing Doc
8-K 1.01,1.02,2.03,3.02,8.01,9.01 Filing Doc
8-K 8.01,9.01 Filing Doc
8-K 5.07 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
DEFA14A Filing Doc

Insider forms

Form 3 / 4 / 5 from EDGAR · 21 rows shown

Filed Form Detail Links
4 Period Aug 31, 2026 Filing Doc
4 Period Aug 26, 2026 Filing Doc
4 Period Aug 18, 2026 Filing Doc
4 Period Aug 17, 2026 · 2 forms Filing Doc
4 Period Aug 10, 2026 Filing Doc
4 Period Jul 30, 2026 Filing Doc
4 Period Jul 21, 2026 Filing Doc
4 Period Jul 16, 2026 Filing Doc
4 Period Jul 15, 2026 Filing Doc
4 Period Jul 2, 2026 Filing Doc
4 Period Jul 1, 2026 · 2 forms Filing Doc
4 Period Jun 26, 2026 Filing Doc
4 Period Jun 25, 2026 · 2 forms Filing Doc
4 Period Jun 15, 2026 Filing Doc
4 Period Jun 11, 2026 Filing Doc
4 Period Jun 4, 2026 · 2 forms Filing Doc
4 Period May 18, 2026 Filing Doc
4 Period Apr 27, 2026 Filing Doc
4 Period Apr 22, 2026 Filing Doc
4 Period Apr 17, 2026 Filing Doc
4 Period Apr 14, 2026 Filing Doc

Updated 4 days ago Source: SEC EDGAR submissions All on EDGAR

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue $170.28M $178.96M $276.98M
Gross profit * $94.72M $106.88M $205.62M
Gross margin * 55.6% 59.7% 74.2%
Net income -$225.25M -$159.49M -$59.5M
Net margin * -132.3% -89.1% -21.5%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $410.19M $283.75M $300.18M
Total non-current assets * $250.95M $255.62M $212.55M
Total assets $661.13M $539.38M $512.74M
Total current liabilities $88.02M $98.05M $89.92M
Total non-current liabilities * $264.84M $238.84M $197.82M
Total equity $308.4M $202.71M $218.79M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$156.32M -$95.21M -$45.99M
Cash from investing $129.65M $77.79M $37.95M
Cash from financing $2.24M $0.241M $30.4M
Net change in cash -$24.43M -$17.18M $22.37M

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

ownership over time

filing count by report period · click a bar for that quarter’s holders